|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 204.92 USD | +4.53% |
|
+4.92% | -10.55% |
| May. 15 | Natera Gets FDA Approval for Bladder-Cancer Test | DJ |
| May. 15 | Natera's Signatera CDx Approved by FDA as Companion Diagnostic in Muscle-Invasive Bladder Cancer | MT |
- Stock Market
- Equities
- NTRA Stock
- Charts Natera, Inc.
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
















